Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 851 of 6351
-
New CAR T-Cell therapy targets tough lymphomas
Disease control Recruiting nowTo find the highest tolerable dose of JV-213 (a type of autologous CAR T cell therapy) that can be given to patients who have B-cell lymphoma that is relapsed or refractory.
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Needle vs. IV: which isatuximab method works best for myeloma?
Disease control CompletedThe trial aims to demonstrate the non-inferiority of subcutaneous to intravenous isatuximab administration in transplant-eligible patients with newly diagnosed multiple myeloma.
Phase 3 • Sponsor: University of Heidelberg Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New TB drug cocktail aims to shorten treatment
Disease control Recruiting nowThis is a phase 2B/C, open label platform study that will compare the efficacy, safety of experimental regimens with a standard control regimen in participants with newly diagnosed, drug sensitive pulmonary tuberculosis. In stage 1, participants will be randomly allocated to the…
Phase 2 • Sponsor: Michael Hoelscher • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
One shot for two viruses? moderna tests combo mRNA vaccine
Vaccine CompletedThe study is divided into 2 parts: Part 1 and Part 2. The purpose of Part 1 of this study is to generate sufficient safety, reactogenicity, and immunogenicity data to enable selection of an mRNA-1083 vaccine composition and dose level to evaluate in a subsequent Phase 3 clinical …
Phase 1/2 • Sponsor: ModernaTX, Inc. • Aim: Vaccine
Last updated Jun 27, 2026 08:06 UTC
-
Brain zap trial hopes to quiet OCD for good
Disease control Recruiting nowThis is a multi-site, double-blinded, randomized, crossover study design for SEEG-guided 4-lead DBS for treatment-refractory OCD, followed by open-label stimulation for an additional 6 months. The study will be conducted in 3 stages: Stage 1 will consist of SEEG brain mapping and…
Sponsor: Casey H. Halpern, M.D. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New injection shrinks sarcoma tumors in early trial
Disease control Recruiting nowA Phase IIa open label study evaluating the preliminary efficacy of intratumoural tigilanol tiglate in advanced and/or metastatic soft tissue sarcoma of the extremities and body wall.
Phase 2 • Sponsor: QBiotics Group Limited • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could junk food compounds fuel a rising esophagus disease?
Knowledge-focused Recruiting nowEosinophilic esophagitis (EoE) is a chronic antigen-mediated inflammatory disease of the esophagus that affects both children and adults. The incidence and prevalence of EoE is rapidly increasing in Western countries with an estimated incidence of 6.6 per 100,000 person-years (95…
Sponsor: Federico II University • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
One-Time eye injection could slow blindness in retinitis pigmentosa
Disease control OngoingThis is a two-step, multicenter, Phase I/II study including an open-label dose-escalation phase (Step 1) and a three-arm, controlled, double-masked, randomized extension phase (Step 2), in subjects with advanced RCD due to a mutation in the RHO, PDE6A, or PDE6B gene (Step 1), or …
Phase 1/2 • Sponsor: SparingVision • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Triple threat: new drug cocktail aims to extend life in elderly lung cancer
Disease control OngoingThis study aims to explore the safety and efficacy of etoposide capsules combined with Anlotinib and Envafolimab in elderly patients with extensive small cell lung cancer.This is a single-center, single-arm exploratory clinical study. 30 patients with extensive small-cell lung ca…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Smart insulin pump could ease diabetes in cystic fibrosis patients
Disease control OngoingThe main objective of this study is to determine whether closed-loop glucose control is superior to standard insulin therapy with continuous glucose monitoring (CGM) in young people (≥16 years) and adults with cystic fibrosis (CF) related diabetes. This is an open-label, multice…
Sponsor: University of Cambridge • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a tiny implant save thousands of heart failure patients?
Disease control Recruiting nowBRITISH is a UK multicentre trial of patients who have been diagnosed with heart failure due to Non-Ischemic Cardiomyopathy (NICM, or heart failure that is not caused by blocked heart arteries. Participants will be randomised into two groups. Half the participants will receive an…
Sponsor: University Hospital Southampton NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Alcohol injection plus standard procedure may calm deadly heart rhythm
Disease control Recruiting nowComparative effectiveness randomized clinical trial, comparing endocardial radiofrequency ablation alone vs radiofrequency ablation combined with venous ethanol in patients with ischemic ventricular tachycardia -Venous Ethanol for Left Ventricular Ischemic Ventricular Tachycardia…
Phase 2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
AI matchmaker for mental health: which digital therapy works best for you?
Disease control Recruiting nowDigital mental health interventions are a cost-effective and efficient approach to expanding the accessibility and impact of psychological treatments; however, little guidance exists for selecting the most effective program for a given individual. In the proposed study, decision …
Sponsor: Boston University Charles River Campus • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
A new program aims to ease the 'Lost in Transition' struggle for cancer survivors
Disease control Recruiting nowThis study, using a sequential multiple assessment randomized controlled trial (SMART) approach, will evaluate a cancer survivorship care intervention on physical symptom distress, weight management, self-efficacy in managing cancer and health-related quality of life among Chines…
Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Smart insulin pump shows promise for type 2 diabetes control
Disease control CompletedThis is a single arm, multi-center, prospective study that will evaluate the safety and efficacy of the Omnipod 5 Automated Insulin Delivery System in adults with type 2 diabetes requiring insulin therapy.
Sponsor: Insulet Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New blood thinner aims to match apixaban in preventing strokes with fewer bleeding risks
Disease control OngoingThe purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-central nervous system (CNS) systemic embolism.
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New eye drops aim to heal corneal damage in rare disease
Disease control Recruiting nowThe objective of this study is to compare the safety and efficacy of RGN-259 to placebo for the treatment of Neurotrophic Keratopathy (NK)
Phase 3 • Sponsor: ReGenTree, LLC • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Nerve block calms deadly heart storms in small trial
Disease control CompletedThe objective of our study was to evaluate the effectiveness of stellate ganglion block (SGB) and of the bilateral cardiac sympathetic denervation (BCSD) in patients with electrical storm refractory to conventional treatment..
Sponsor: Jose Manuel López González • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New combo therapy shows promise for premenopausal breast cancer patients
Disease control CompletedA multicenter, prospective, open, randomized cohort, non controlled phase II clinical study to evaluate the effectiveness and safety of Darxil combined with Exemestane+goserelin neoadjuvant endocrine therapy in HR positive and HER2 negative premenopausal breast cancer patients. T…
Phase 2/3 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could a weekly shot help people with type 1 diabetes lose weight and control blood sugar?
Disease control CompletedThe purpose of this study is to assess the use of once weekly semaglutide injection in inadequately controlled obese adults with type 1 diabetes (T1D) using FDA-approved hybrid closed-loop therapies.
Phase 2 • Sponsor: Viral N. Shah • Aim: Disease control
Last updated Jun 26, 2026 13:16 UTC